|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1995-2-10
|
|
pubmed:abstractText |
Gastrointestinal involvement is frequent in patients with scleroderma. Erythromycin, a macrolide antibiotic, has been shown to accelerate gastric emptying in normal subjects and diabetic patients. The present study investigated the effects of acute erythromycin administration on gastric and gallbladder motility in patients with scleroderma and gastrointestinal involvement.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
807-13
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7824860-Adult,
pubmed-meshheading:7824860-Aged,
pubmed-meshheading:7824860-Aged, 80 and over,
pubmed-meshheading:7824860-Eating,
pubmed-meshheading:7824860-Erythromycin,
pubmed-meshheading:7824860-Fasting,
pubmed-meshheading:7824860-Female,
pubmed-meshheading:7824860-Gallbladder Emptying,
pubmed-meshheading:7824860-Gastrointestinal Motility,
pubmed-meshheading:7824860-Humans,
pubmed-meshheading:7824860-Male,
pubmed-meshheading:7824860-Manometry,
pubmed-meshheading:7824860-Middle Aged,
pubmed-meshheading:7824860-Scleroderma, Systemic
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.
|
|
pubmed:affiliation |
Gastroenterology and Digestive Endoscopy Clinic, University of Perugia, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
